Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureMark S. Gold, Daniel M. Blumenthal
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
GLP-1 receptor agonist and GIP/GLP-1 receptor dual agonist therapeutics at the intersection of alcohol use disorder, obesity, and cardiometabolic dysfunction
2026
From bedside to bench and back again: A 30-year saga
10.1016/j.physbeh.2011.04.027 · 2011
Neurobiology of food addiction
2010
Hormonal and neural mechanisms of food reward, eating behaviour and obesity
10.1038/nrendo.2014.91 · 2014
Food and addiction—Sugars, fats and hedonic overeating
10.1111/j.1360-0443.2011.03373.x · 2011
Animal models lead the way to further understanding food addiction as well as providing evidence that drugs used successfully in addictions can be successful in treating overeating
10.1016/j.biopsych.2013.04.022 · 2013
AgRP neurons are required for the weight-lowering effects of GLP-1 receptor agonists in female mice
10.1073/pnas.2614476123 · 2026
Once-weekly semaglutide in adults with alcohol use disorder: A randomized clinical trial
10.1001/jamapsychiatry.2024.4789 · 2025
Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: A randomised, double-blind, placebo-controlled trial
10.1016/s0140-6736(26)00305-3 · 2026
Naltrexone: A history and future directions
2018
No additional external references are available.